uniQure
QURE • NASDAQ
uniQure is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Matthew Craig Kapusta, with a market cap of $1.5B.
CEOMatthew Craig Kapusta
Market Cap$1.5B
Biotechnology
Healthcare
Employees480.0
Websiteuniqure.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for uniQure
Date
Friday, May 8, 2026 (in 3 months)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.83
Revenue Estimate
$7.7M
Earnings History
Past 11 earnings reports for uniQure
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 10, 2025 | Q3 2025 | -$1.38Est: -$0.79 | -74.7% | $3.7MEst: $5.4M | -32.1% |  10-Q |
| Jul 29, 2025 | Q2 2025 | -$0.69Est: -$0.81 | +14.8% | $5.3MEst: $5.8M | -9.7% | 10-Q |
| May 9, 2025 | Q1 2025 | -$0.82Est: -$0.93 | +11.8% | $1.6MEst: $5.9M | -73.4% | 10-Q |
| Feb 27, 2025 | Q4 2024 | -$1.50Est: -$0.51 | -194.1% | $5.2MEst: $18.5M | -71.7% | 10-K |
| Nov 5, 2024 | Q3 2024 | -$0.91Est: -$1.00 | +9.0% | $2.3MEst: $7.1M | -67.8% | 10-Q |
| Aug 1, 2024 | Q2 2024 | -$1.16Est: -$1.25 | +7.2% | $11.1MEst: $6.9M | +61.5% | 10-Q |
| May 7, 2024 | Q1 2024 | -$1.36Est: -$1.33 | -2.3% | $8.5MEst: $6.2M | +36.2% | 10-Q |
| Feb 28, 2024 | Q4 2023 | -$1.53Est: -$1.45 | -5.5% | $6.7MEst: $5.6M | +19.7% | 10-K |
| Nov 7, 2023 | Q3 2023 | -$1.88Est: -$0.85 | -121.2% | $1.4MEst: $29.8M | -95.3% | — |
| Aug 1, 2023 | Q2 2023 | -$1.44Est: $2.05 | -170.2% | $2.4MEst: $207.7M | -98.8% | 10-Q |
| May 9, 2023 | Q1 2023 | -$1.63Est: -$0.95 | -71.6% | $5.3MEst: $28.3M | -81.2% | 10-Q |